-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
-
Summary
-
Vitro Biopharma, Inc. quarterly Goodwill history and growth rate from Q3 2022 to Q2 2024.
- Vitro Biopharma, Inc. Goodwill for the quarter ending July 31, 2024 was $3.61M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)